REGISTERED CHARrfY NUMBER: 290959 REPORT OF THE TRUSTEES AND UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023 FOR BIUTISH GYNAECOLOGICAL CANCER SOCIETY
BIUTISH GYNAECOLOGICAL CANCER SOCIETY COFrfENTS OF THE FINANCtAL STATEMEI¥4TS FOR THE YEAR ENDED 31 DECEMBER 2023 Page Report of the Trustees I to 4 Independent Examiner's Report Statement of Financi¥Jl Activities Bal*n¢e Sbeet Noles lo the Financi St&ttmeDts 8 to 13
BRITISH GYNAECOLOGICAL CANCER SOCIETY REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2023 The tnist¢¢s prescnt their report with the fit]aJKtal stalements of the ¢hariry for th¢ year ended 31 Decembcr 2023. The trustees have adopt¢d the provisions of Aecoutsting and Report&ng by Charities.. Stat¢rn¢nt of R¢comm¢nd¢d Pra¢ti¢¢ applicable to chariiies preparing th¢ir a¢¢ounts in accordance M4th the Financial Reporting Stsndard applicable in the UK and Republi¢ of Irela[ {FRS 102) (effective l January 2019). OBJECTIVES AND ACTIVITIES Objeetlves and &Sms Th¢ obj¢ds ofthe charity are to advance the lence and art of Bynaeeological oncology for the benefit of the public. It a¢hi¢v¢s Its owtt objectives by- - Making grants to individuals - SponsoTing or undertaking r¢s¢arch in 8ynaecological oncology {fyOnc) Providing advocacy, advice and infoThnation - Rurming consensus meetings for specific topics tn Gynon - Publishing clinical guidelines fr>r diagt)osis and management of gynaoI087¢aI can¢crs - Working with the Royal College of Obstetiician5 and Gynae¢ologists io develop training curricula -supporting professional development of membership - Acting as atl umbr¢lla or resource body Supporting one national annual scientsfic mccting a year l(MTrking at aspeets of 8ynaecologi¢al oncology Awarding prizes to the besl oral and post¢r prcsentation at thc ASM Publk b¢neflt The tNstees confirm ¢hai th¢y have refred io the guidance contain¢d in th¢ Charity Cornmission'5 general 8uidance OD publi¢ ben¢fJt when reviewing the Chariws airns and objectives and in planning tUre activities. ACHIEVKMENT AND PERFORMANCE Chsrltable Acthltle$ The BGCS continu¢s to thrive with an increase in membership to beyond 700 h¢wlth¢aTe woikm iwluding surg¢ons, oncologists, nurscs, scienrists and associated healthcare workeTS. The key ainLs of ihe BGCS are to be advocates in th¢ manag¢mcnt of Gynaecological Cancer by education and protill8 best praciice in the care of women diagllosed with gynaecological can¢er. Tk centrc W)int of the yeaTly activity Temains the annwal s¢ientifie meeiing. In 2023 this took place ill Aberdeen with over 4(K) attendees over 2 days. The standard of thc mecting was extremety high and we received excellent delegate feedback. Iknring 2023. th¢ BGCS held a dedicated one day meeting for unit lead clinicians, fvrth¢r strengthening th¢ rol¢ of the BGCS in supporting clinicians in smaller canccr units. In January. thc BGCS held the annual trainee8 meeting for sub speciality trainees. Trajning of our futur¢ gynaeeological caneer healthcare professionals remains a priority, we support the trainees Mryth educational grants and th¢ opportunity to attcnd thc Naiional Peritoneal Car¢inomatosis Centre in Basingstok¢ as a training fellow. The BGCS havc dcv¢lop¢d a new trdining program in conjun¢tson with the GMC and RCOG. Notably, th¢ BGCS are developing rtursing standards and guidelines which will be published in 2024 following peer review. Th¢ major charitable actions of the BGCS are Providing grants for research. During 2023, we nded a post doctoral research grant in conjunction with Wellbeing of Women and also S11¢[ pew teyiewed research gtaT)ts through the BGCS. In addition we offer various prizes and travel wts to members of th¢ society. Oyeiall, ttbe BGCS Temains a tbriving society aud durin8 2023 a¢hieved its aims of advocating for diagnosis, management and Ca of women diagnosed with Ge¢010glcal can¢¢r. FINANCIAL REVIEW FiTh*neiil position Thc financial position for the year thows d¢ficit iTJcome over expenditlre of £3.846 (2022- £66,434 su1$ income over expendiwie). The charity has bank balances of £546,843 (2022.. £566,114). The trnsiees consider the rmancial position of thc chaTity to be satisfactory. Page I
BRrrIsH GYNAECOLOGICAL CANCER SOCIETY REPORT OF THE TRUSTEES FOR THE YEAR ETr4DED 31 DECEMBER 2023 FINANCIAL RETrryEW Reserycs polley Thc Treasurer will monitor the finan¢ial re5ery¢s of the charlty and is reSpolb]e for recollJtllendiDg a $¢V¢S policy which will be reviewed by the Trnstees on an antmal basis. The current re5¢ry¢s policy was agreed at the council meeting in June 2017 and ts based on th¢ following principals.. -The BGCS should k¢ep reserv¢s that c4n sustsin the workin¥ of the clwity for a y¢ar. -The BGCS should not keep resetves that are excessive. Assuming the r¢quir¢m¢nt for maintaining reserves for one year is met. the cbarity should avoid k¢eping r¢s¢TV¢S greater than 800/0 of the sum of the atjnual incon]e T ndit¢ av¢ra8¢d ovu fiv¢ years -Wh¢n reserves are excessiv& the charity should explore new aV¢nU of ¢l]aritable activity. Under the CUtnt 8¢rVeS policy reserve5 at the year end cotjtinuc to bc high dpIte planned ¢xp¢nditur¢ on funding the feasibility pilot of a Naiional Ovarian Cancer Audit F¢asibility Pilot, furth¢r ¢xp¢nditwe on the Webinar educational programme. ffijnding of 2 consrnsus me¢tings and fvnding of an additional sub-group. tn 2020 Council agreed to additionèl spending to support the Traineesfjrainers Annual Summit, discounted registration fees to support t)ur5e members attending Annual Scientific Meeting, incrcascd cxpcnditure on PriTKS, awards, tTavel fellowships and researchlaudit grattts. STRUCTURE, GOVERNANCE AND MANAGEMENT Goverthy d•eumeDt Th¢ Charity is controlled by its goveming document, a de¢d of irusL and ¢oll5titut¢5 an unincorpordted charity. The British Gynaecologiral Canc¢r So¢i¢ty is WlJ5titu¢ed UDder a deed adopted at the time of the iMauguta] I¢tIng QD the 6th Ortob¢r 1984 alld am¢nd¢d on the 6th May 1988, 30th April 1994. 20th May 2004 at]d 21 Jun¢ 2013. It is a registered drity, number 290959. R¢eruitThent 8Dd &ppolntmellt of neryv trustees The office holders of tbe Society (PresTdent, Hon Secretary and H¢)n Trca8urer) have automatically held the role of Trustee since the inception of the Society in 1984. It wa5 decided that at the sun]nr council meeting of the society 8th July 2015 that the society should fornulise rhe appointment of non-executive tru%tee5 and this Ivas ratified at the AGM of 10th July 2015. It was decided thai the offieets of thc council as described in thc ConStition of the BGCS 2015 Section (3) Wold be joltsed in thc rolc of truste¢s by no1¢s5 than two and no more than four non-votittg trustees to serve for thrce ycars_ Th¢ airn of Council was to seek applications from the most experienced individuals within the Tnembcrship and it was envisaged thai such Candidates would be either nearing th¢ ¢nd of or have retired clinical practice. The memberskn"p was asked to self nilminate for the position or n¢)minate a colleague if they were agr¢¢abl¢ tt> taking up the Positio by Oetob¢r 31st 2015. Subsequently two individuals were Identifi who were approached and who l)oth accepted the position of trustee. Their appointmellt wa5 ratifi at AGM of 15th May 2016. The newly appointed Inlee$ were bent an invitation letter whioh dirwled them to background reading regarding their ststutory and soriety respollsibiliti¢$. Both trnstees accepted by retum of post. The firsi responsibility delegat¢d to th¢ two n¢wly appoillt¢d truste¢5 was the recruitment of a third non voting truslee. identified at the wunril meeting of 9th February 2017 and subsequently directly approached with the sam¢ invitation letter used previously. The third non-voting trustee accepted the position foTrnally on 13th Marcb 2017 and this appointment was ratified al the AGM on 15th J¢ 2017, this person has now st¢pped down from the lrnstee position for personal reasons at the end of 2020. A n¢w IEUStee wryth a non medical background and expenise in legal affairs has sincc been appointcd. The Cuent constitution (2017) stat¢s in relation to tnJstees:_ S¢¢ti¢)n 2 (Membership of the Society) Trustees l. TrnSt¢ are required by thc Chartty Commi&sion. 2. Tnjstees shall be recommended by Council and ratified by the AGM. 3. Tnjstees sball serve a rninitnum terni of three years and this may be rettewable for up to two fiJrtb¢r t¢rn. In eertain circillnstances th¢ tcrni may b¢ extended by a further one year to allow for ov¢rlap and ensuring suitable candidaics are in post to provide continuity to the Soci¢ty. 4. There shall be a Tninimum of 2 and a Ml[M of 4 trustees who will not have voting rights. 5. Trust¢¢$ shall be individuals whose qualifications and motivation would be of value to the BGCS in promoling its goals within the rules of lis charitable stas. Page 2
BIUTISH GYNAECOLOGICAL CANCER SOCIETY REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2023 STRUCTURE, GOVERNANCE AND MANAGEMENT Risk management The trustees hav¢ a duty to identify and review the Tisks to which the Charity is exposed and to et]sur¢ appropriate controls ar¢ in place to provide Teasonablc a$surat]c¢ against fralld and error. REFERENCE AND ADMINISTIi4TIVE DETAILS Reglstered Cbarity number 290959 Principal address Gl&slyn Ffordd Y Parc Parc M¢Dai Bangor LL57 4FE Try$t¢es Mr C Chan Professor J Shepherd MsBRai Mr S Dobbs- (President) Mr A J Phillips- {Treasurer) Mr K B Gojjar- (Secretary) Independent ExamlDer Colin Bell FCCA Williams Denton Cyf Chartered Ccrtified A¢countsnts Glasl Ffordd y Parc Parc M¢nai Bangor Gw>Thdd LL57 4FE TRUSTEES, RESPONSIBILITY STATEMENT Th¢ twst¢e5 arc responsible for preparing the Report of the Trustees and the firLan¢ial llatements in accordance with applicable law and United Kingdom Accoullting Standards (United Kingdom G¢ncrally Accepted Accounting Practice). The law applieable lo ch8rities in England and Wales, the Charitie5 Act 2011, Charity (Accounts and Rep<)rtsl Regulations 2008 and the proYisAoJL% of the trnst deed requires the trust¢¢s to prepare fioancial statements for each funtIal year which give a twe and fair vi¢w of the state of affairs of the charity and of the incoming resources and application of resour¢es, including th¢ and expendituie, of the charity ftsr that period. In preparing those financial stat¢mentb. the InleeS are required to select suitable accounting poli¢i¢s and then apply them consistently; ob8¢rve the metbods and principles in the Charity SOR. m&ke judgements and ¢StInte5 that are reasonable and prudent; prepare the finan¢ial stat¢m¢nts on the going concern basis unless it is inappropriate to preswne that the charity Hqll cgntinue in business. Page 3
BRITISH GYNAECOLOGICAL CANCER SOCIETY REPORT OF THE TRUSTEES FOR THE IIAR ENDED 31 DECEMBER 2023 TRUSTEES, RESPONSIBILITY STATEMENT- £gDtinued Th¢ trust¢¢S Jre responsible for keeping proper accounting records Mthich disclose wlth reasonable aecurary at any lime the financial position of the cbarity and to enable thern to ensur¢ that the financial statements comply with the Chariti¢s Aet 2011, the Charity (Accounts znd RqM>rt¥) Regulati¢)ns 2008 and the provisions of the bust deed. Tb¢y are 41sts responsible for safeguarding the a55et5 of the chaiity and h¢tL¢¢ for takillg reasonable steps for tbe prevention and detection of fraud al oth¢r 1c8u1arItic$. Approved by order of the board of trustees on 24 O¢tob¢r 2024 and signed on its behalf by. Mr S Dobb5 - Trustee Pag¢ 4
IriDEPENDENT EXAMINER'S REPORT TO THE TRUSTEES OF BRITISH GYf4AECOLOGICAL CANCER SOCIETY Independent examiner's report to tbe trustees of Brlttsh Cynaecologleal Caneer Soclety I report to the charity truste¢s on my examination of the accounts of British Gynae¢ological Cancff Soci¢ty Ithe Trust) for the year endcd 31 Dccember 202J. Re$pon$tbllltlu #nd b#sis fjf report As the charity trus*es of the Trust you are responsiblc for the prep&rAtion of the accounts in accordance with the requir¢meDts of th¢ Chariti¢s Act 2011 ('the Aet,). I r¢port in respect of my examination of the Tnt'S accots out under Scctiott 145 of the Act and in carrying out my examitiation I have follow¢d all applicable DirectiOtsS given by the Charity Commission wid¢r S¢ction 145{5){b) of the A¢l. Independent examther's St4¢ement Sinc¢ your ¢harity's gross income exceeded £250,01)O your examiner must be a eMber ot. a listed body. I can confll that l am qualified to undertak¢ th¢ ¢xamina(ion because l am a member of th¢ Association of Chartered Certified Accountants, which is one of the listed bodies. I have completed my examin10. I confirm ihat no material maiters have come to my attention in connection with the ekwninatioD giving me ckusc io believe that in any material resp¢ct: aceounting records were not kept in rcspccl of the Tnjsi as required by Section 130 of the Act. or the a¢counts do not accord those Tecords; or th¢ accounts do not comply the applicable requiTements concerning thc form and wntent of accounts sti out in the Charities (Accounts and Report5) R¢gulations 2008 other than any requirement that the accounts give a tru¢ arrfl fair view which is not a mallcr considered as part of an independent examination. I have no concerns and have come across no oth¢r matters in cortncctithj with the examination to which attenti¢)n should be drawn in this report in order to enable a proper understsnding of the accounts to be reached. Colin B¢ll FCCA Williams D¢niOn Cyf Chattered Certified Accountallts Glaslyn Ffordd y Parc Par¢ M¢nai Bangor Gwyn¢dd LL57 4FE 24 October 2024 Page 5
BRITISH GYNAECOLOGICAL CANCER SOCIETY STATEMENT OF FINANCIAL ACTIVITIES FOR THE YKAR ENDED 31 DECEMBER 2023 21123 Total fw)ds 2022 Total Unrestrirted fimd Restri¢t¢d Notes INCOME AND ENDOWMEN]S FROM Donations and l¢8a¢i 383 Charltable attliltles To advance the science and art of gynaecological oloI08Y for the benefit of the public 322,952 322,952 316.542 Inyeslment income 6,624 6,624 188 Total 329J76 329,576 317.113 EXPENDITURE ON Chirltable activltles To adva¢ th¢ s¢ience and art of a¢cOlogical oncology for the benefLt of th¢ publi¢ 333,422 333A22 250.679 NET INCOME1(END]TuRE) (3,846) {3,846) 66.434 RECONCILIATION OF FUNDS Total fimds brought forward 639,445 639,445 573.011 TOTAL FUNDS CARRIED FORWARD 635,599 635,599 639,445 CONTIIYUING OPERATIONS All incomc and expenditur¢ has ariscn from continuing activiues. Th¢ Th)t¢s forni part of th¢s¢ financial statem¢nls Pag¢ 6
BRITISH GYNAECOLOGICAL CANCER SOCIETY BALANCE SHEET 31 DECEMBER 2023 2023 Total funds 2022 Total Unrestricted fiuid Restricted fiwd Notes CURRENT ASSETS D¢btots Cash at bank 94,595 546,843 94,595 546.843 85,306 566,114 641,438 641,438 651,420 CREDITORS Amounts falling due Thithin on¢ y¢ar 10 (5,839) {5,839} (11,975) NET CURRENT ASSETS 635,599 635,599 639,445 TOTAL ASSETS LE&S CURRENT LIABILITIES 635,599 635,599 639,445 NET ASSETS 635,399 635,599 639,445 FUNDS Unrestricted fvnds 635,599 639,445 TOTAL FUNDS 635,599 639,445 Th¢ financlal statements were approved by the Board of Trustees and authorised for issue on 24 Octob¢r 2024 and wer¢ signed on its b¢half by.. Mr S Dobbs- TnLStce Th¢ notc5 fom part of th¢se fillancial statements Pagc 7
BRITISH GTrThAECOLOGICAL CANCER SOCIETY NOTES TO THE FINANCIAL STATEMEJYTS FOR THE YEAR ENDED 31 DECEMBER 2023 ACCOUNTING POLICtES B45is of Prering the finlldl statements The fmancial statements of the charity, which is a public benefit entity under FRS 102, have been prepared in accordan th the Charities SORP (FRS 102) 'Accounting and Reporting by Charilies: Statement of R¢¢ommended Practice applicable to charities preparing thcir ac¢ounts in accordance with tbe FAnan¢ial Reporting Standard applicable in th¢ UK and Republic of Ireland (FRS 102) (effective l January 2019),, Financial Reporting Standard 102 'The Ftnancial R¢portin8 Standard opplicabl¢ in the UK and Republic of Ireland, aJ)d the Charities Act 2011. Th¢ f]nallci21 ststements have been prepared under the histOTical cost convention. Income All i(¢ is recognised in the Ststement of Financial Activities one¢ the ¢h8rity has entitlement to the fiu)ds, it is probable that the income will be received and th¢ amount ¢an be measured reliably. Expenditure Liabilities are recogtsised &8 expenditure as soon as th¢r¢ 18 0 Icg31 or constNctt"ve obligation cotnmitting the ch8riry to that expcndithrc, it is probablc that a transfer of economi¢ benefAts wiu be required in settloncot and the amount of thc obligation can be measured reliably. Expenditure is accountcd for on an ac¢ruals basis and ha5 b¢cn classified under beadings that aggregate all cost relat¢d to thc tstcgory. Where costs caDDot be dirwtly attributed to particular headings th¢y have been allocated to &tivities on a basis ¢onsi5tent with the use of resourc¢s. The charity is exempt from corporation tax on its cbaTitibl¢ artiviti¢s and 15 r¢gist¢red for VAT purposes. FuDd *t¢thAlIng Unrestricted funds can be used in aeeordance with the charitsble objectives at the discretion of the trusiees. Restricted fu]Jds Can only be used for parriculaT Tesiricted prpoSeS within the objects of the charity. Rcstrictions arise when specified by the donor or when fithds aTe rdiS¢d for particular restricted purposes. Further explanation of th¢ nature and purFxise of each ffijnd is included in the Ate& to the financial statcments. II¥VESTMENT INCOME 2023 2022 Dwsit acwunl inl¢r¢st 6.624 188 Page 8 ¢ontinued..
BRITISH GYNAECOLOGICAL CANCER SOCIETY NOTES TO THE FINANCIAL STATEMENTS- contlnued FOR THE YEAR ENDED 31 DECEMBER 2023 INCOME FROM CHARITABLE ACTIVITIES 2023 2022 To advance the science and art of gynaecologieal onc(¥logy for the benefit of the public To Advance the scien¢e and art of g)Thecological oncology for the b¢ncfit of th¢ public To advance the s¢ietJ¢¢ and art of g)Thecological oneology for the benefit of the publie To adv#n¢e th¢ $¢i¢n¢¢ and art of gytMetologi¢al oncology for the benefit of the publi To advance the science and art of gsry)ae¢olo8i¢al onwlogy for the benefit of thc publie To advance the science Alld art of gynaecological oncology for the benefit of the publi¢ To advance the science and art or gJTLa¢¢ologi¢al on¢ology for the benefit of the public To advance ihe scienc¢ and art of gynaecol0eal oncology for the benefit of the publi To advÈnce the science and art of ge¢010glcl oncology for the benefit of the public Grants 16,8110 Sponsorships 2,500 Delegate fees 14,185 19,835 Subscriptions 60.1145 53.012 Subvention 6,11(10 ASM Social Programme 7,992 ASM Delegate income 87,310 123,195 ASM STM)nsorship income 118,71)0 118.000 Sundry iwom¢ 7J37 322,952 316,542 Grants receiv¢d, iwlud¢d in the above. are as follows.. 2Q23 2022 R K Wright Ovarian Cancer A¢tion I,00 15JOO 16000 Page 9 continued...
BR]TISH GYNAECOLOGICAL CANCER SOCIETY NOTES TO THE Fif4ANCIAL STATEMENTS- CDlitlnu FOR THE YEAR EF4DED 31 DECELVIBER 2023 CHARrrABLE ACTIVITIES COSTS Support costs (see notc 5) Direet Costs Totals To advanc¢ the science and art of gylla¢cologiul oncology for the benefit of tbe public 297,652 35,7711 333,422 SUPPORT COSTS Govemanee sts Manag¢ment Totals To advance the l¢n¢¢ and art of gIOI0g)¢ol oncolo8y for the benefit of the public 27,552 8,218 35,77 INDEPEF4DENT EXAMINER'S FEES 21b23 2022 Iodependent examineds f¢es 3,600 2,200 TRUSTEES, REMUNERATION AND BENEFITS There were JM) trtees, remuneration or oÉber benefits for the year ended 31 Decenth¢r 2023 nor for the year ettded 31 De¢ember 2022. Trustees, expensey 2Q23 2022 Trust£¢s' expense5 4,618 2.338 COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES UnrestsiLtrd fund Restricted fvnd Total INCOME AND ENDOWMENTS FROM Donaiions and legacies 383 383 Ch4rit*ble a¢tivitles To advance the scienee aDd art of gynaeeologieal oncology for thc bcncfit of the public 316542 316.542 Investm¢at iti¢ome 188 Ttsta] 317,113 317.113 EXPENDJTURE ON Page 10 continued...
BIUTISH GYNAECOLOGICAL CANCER SOCIETY NOTES TO THE FINANCIAL STATEMENTS- eontlnued FOR THE YEAR ENDED 31 DECEMBER 2023 COMPARATIVES FOR THE STATEMENT OF FINANCJAL ACTIVITIES- continued Unrestricted Restricted fiwd fvnd Total fidS Chgrftable acdvltles To advance the science and art of gynaecologi¢al on¢ology for the benefit of the public 250.679 250.679 NET INCOME 66.434 66,434 RECONCILIATION OF FUNDS Total fimds broughr fonvard 573,011 573,011 TOTAL FUNDS CARIUED FORWARD 639.445 639,445 DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR 2023 2022 Other drbto VAT 88,186 4J16 2,093 61,308 8,570 15,428 Pr¢pa)rynents 94.595 85.306 CREDITORS: AMOUNTS FALLING DUE IVITHIN ONE YEAR 2023 2022 Other ¢reditors Accruals and defeTred incoll Ac£rued expens¢s U39 7,276 2.500 2,199 3,600 5,839 11,975 ii. MOVEMKNT IN FUNDS Nel moveD]eut ID funds At 31.12.23 At 1.1.23 Unrdtrltted funds General fund 639,445 (3,840) 635,599 TOTAL FUNDS 639,445 (3.840 635.599 Pagell continued...
BIUTISH GyNAECOL(IcAL CANCER SOCIETY NOTES TO TIIE FINANCIAL STATEMENTS- eonrfnued FOR THE YEAR ETr4DED 31 DECEMBER 2023 11. MOVEMENT IN FUNDS- continued Net movement in fund& includcd in the aknY¢ are 18 follows: Incorning resources Re50UT¢es exp¢nd¢d Movement in fund5 Unrestricted General fund 329,576 (333,422) {3,846) TOTAL FUP4DS 329,576 (333.422) (3,846) CompY4ratives for movement in fuDd$ Net movement in fimds At 31.12.22 Ar 1.1.22 Unrestrleted funds G¢n¢ral fiind 573,011 66.434 639,445 TOTAL FUIYDS 573,011 66.434 639,445 Comparative movcmcnt in fids. included in the abovc aTC as follows.. Incoming resources R¢sourc¢5 expended Movement in fimds Unrestrleted fund$ General fund 317.113 (250,679) 66,434 TOTAL FUNDS 317,113 {250,679) 66,434 A cunEnt year 12 months and prior year 12 months ¢ombin¢d position is as follows.. N¢t movement ID funds At 31.12.23 At 1.1.22 Ullrestrlcted funds Gen¢rdl fimd 573.011 62,588 635,599 TOTAL FUNDS 573.011 62.588 635,599 Page 12 continued...
BRITISH GYNAECOLOGICAL CANCER SOCIETY NOTES TO THE FINANCIAL STATEMENTS- etyntlnlled FOR THE YEAR ENDED 31 DECEMBER 2023 ii. MOVEMEIYT IIY FUNDS- cOntIned A current year 12 monihs and prior year 12 months combined net movem¢nt in fvnd5, includ¢d iD the above ar¢ as follows= Incoming resources Resources expended Movement in funds Unrestricted fvnds ¢neral fi]nd 646,689 (584,1011 62,588 TOTAL FUI¥DS 646,689 (584,1 QI) 62,588 12. RELATED PARTY DISCLOSURES Due to thc naturc of the chaTitys operations and compositign of the board of trngteeg and membership both trust5 and n*mbers will pay subseriptkons and fees to the Charity, other than these no material transactions have been identified which should bc discloscd. Pag¢ 13